Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.73 |
| ▸ | KIF11 | P52732 | 1/20 | 0.63 |
| ▸ | CA2 | P00918 | 2/20 | 0.56 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.56 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.47 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.45 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.45 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.45 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.45 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6000327 | 0.85 | PTPN1 (1.00) | PTPN1KIF11CA2PTPN11SMN1; SMN2 | |
| SCHEMBL6001787 | 0.85 | PTPN1 (1.00) | PTPN1KIF11CA2PTPN11SMN1; SMN2 | |
| SCHEMBL7526843 | 0.84 | PTPN1 (0.67) | PTPN1KIF11CA2PTPN11EPHX2 | |
| SCHEMBL23674890 | 0.83 | KIF11 (0.65) | PTPN1KIF11EPHX2SMN1; SMN2MAPK1 | |
| SCHEMBL15116359 | 0.81 | PTPN1 (0.73) | PTPN1CA2PTPN11SMN1; SMN2MAPK1 | |
| SCHEMBL6001776 | 0.79 | PTPN1 (0.69) | PTPN1KIF11CA2PTPN11SMN1; SMN2 | |
| SCHEMBL6000251 | 0.79 | PTPN1 (0.69) | PTPN1CA2PTPN11SMN1; SMN2MAPK1 | |
| SCHEMBL24767382 | 0.79 | KIF11 (0.64) | KIF11EPHX2SMN1; SMN2MAPK1ALDH1A1 | |
| SCHEMBL6001500 | 0.79 | PTPN1 (0.86) | PTPN1CA2PTPN11SMN1; SMN2MAPK1 | |
| SCHEMBL3378495 | 0.77 | KIF11 (1.00) | KIF11EPHX2SMN1; SMN2MAPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050074668-A1 | Perfluorinated amide salts and their uses as ionic conducting materials | MICHOT CHRISTOPHE (FR) | 2005-04-07 | — | — | US | disclosed |
| US-20030052310-A1 | Perfluorinated amide salts and their uses as ionic conducting materials | MICHOT CHRISTOPHE (FR) | 2003-03-20 | — | — | US | disclosed |
| EP-0850920-B1 | Ionic conductive materials comprising salts of perfluorinated amides and uses thereof | CENTRE NAT RECH SCIENT (FR) | 2002-09-11 | — | — | EP | disclosed |
| US-20020009650-A1 | Perfluorinated amide salts and their uses as ionic conducting materials | MICHOT CHRISTOPHE (FR) | 2002-01-24 | — | — | US | disclosed |
| US-6319428-B1 | Perfluorinated amide salts and their uses as ionic conducting materials | HYDRO-QUEBEC (CA) | 2001-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020009650-A1 | Perfluorinated amide salts and their uses as ionic conducting materials | AFF4, NHERF1, AFF2 | PTPN1 1976/4885KIF11 1575/4885CA2 432/4885 |
| US-20050074668-A1 | Perfluorinated amide salts and their uses as ionic conducting materials | AFF4, AFF2, AFF1 | PTPN1 1972/4885KIF11 2316/4885CA2 287/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.